文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Unraveling the Enigma of Moderate Aortic Stenosis: Challenges and Future Prospects.

作者信息

Santangelo Gloria, Tumminello Gabriele, Barbieri Lucia, Mallardi Giulio Pio Federico, Faggiano Andrea, Moscardelli Silvia, Rossi Andrea, Cozza Fabiana, Carugo Stefano, Faggiano Pompilio

机构信息

Department of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca'Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.

出版信息

J Clin Med. 2024 Jun 14;13(12):3478. doi: 10.3390/jcm13123478.


DOI:10.3390/jcm13123478
PMID:38930005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11204855/
Abstract

According to current guidelines, only clinical surveillance is recommended for patients with moderate aortic valve stenosis (AS), while aortic valve replacement may be considered in patients undergoing surgery for other indications. Recent studies have shown that moderate AS is associated with a high risk of adverse cardiovascular events, including death, especially in patients with left ventricular dysfunction. In this context, multimodality imaging can help to improve the accuracy of moderate AS diagnosis and to assess left ventricular remodeling response. This review discusses the natural history of this valve disease and the role of multimodality imaging in the diagnostic process, summarizes current evidence on the medical and non-medical management, and highlights ongoing trials on valve replacement.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3e/11204855/3fac62d674a6/jcm-13-03478-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3e/11204855/4a2e05db5976/jcm-13-03478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3e/11204855/e262d96d5819/jcm-13-03478-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3e/11204855/3fac62d674a6/jcm-13-03478-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3e/11204855/4a2e05db5976/jcm-13-03478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3e/11204855/e262d96d5819/jcm-13-03478-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3e/11204855/3fac62d674a6/jcm-13-03478-g003.jpg

相似文献

[1]
Unraveling the Enigma of Moderate Aortic Stenosis: Challenges and Future Prospects.

J Clin Med. 2024-6-14

[2]
Managing Patients With Moderate Aortic Stenosis.

JACC Cardiovasc Imaging. 2023-6

[3]
Moderate Aortic Stenosis: What is it and When Should We Intervene?

Interv Cardiol. 2021-5-27

[4]

2017-8-25

[5]
Moderate aortic stenosis: Navigating the uncharted.

Echocardiography. 2024-6

[6]
Is "moderate" aortic stenosis still the right name? A review of the literature.

Arch Cardiovasc Dis. 2023

[7]
Moderate chronic kidney disease and left ventricular hypertrophy after aortic valve replacement for aortic valve stenosis.

J Thorac Cardiovasc Surg. 2010-4

[8]
Left ventricular hypertrophy in valvular aortic stenosis: mechanisms and clinical implications.

Am J Med. 2015-4

[9]
[The best of valvular heart disease in 2006].

Arch Mal Coeur Vaiss. 2007-1

[10]
Aortic Stenosis: Risk Stratification and Timing of Surgery.

Curr Cardiol Rep. 2023-3

引用本文的文献

[1]
Could the Hemodynamic Progression of Aortic Valve Stenosis be Slowed Pharmacologically? The Unsolved Dilemma.

Rev Cardiovasc Med. 2025-2-12

本文引用的文献

[1]
Discordant High-Gradient Aortic Stenosis: Trust the Gradient.

J Am Coll Cardiol. 2024-3-26

[2]
Prevalence and Outcomes of Patients With Discordant High-Gradient Aortic Stenosis.

J Am Coll Cardiol. 2024-3-26

[3]
The Mortality Burden of Untreated Aortic Stenosis.

J Am Coll Cardiol. 2023-11-28

[4]
Aortic stenosis: new insights into predicting disease progression.

Eur Heart J Cardiovasc Imaging. 2023-8-23

[5]
Is "moderate" aortic stenosis still the right name? A review of the literature.

Arch Cardiovasc Dis. 2023

[6]
How can progression be predicted in patients with mild to moderate aortic valve stenosis?

Eur Heart J Cardiovasc Imaging. 2023-8-23

[7]
Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohort.

Int J Cardiol. 2023-8-1

[8]
Value of NT-proBNP and Galectin-3 as Biomarkers in the Follow-Up of Asymptomatic Elderly Patients with Severe Aortic Stenosis.

J Clin Med. 2023-4-20

[9]
Reclassification of moderate aortic stenosis based on data-driven phenotyping of hemodynamic progression.

Sci Rep. 2023-4-24

[10]
Managing Patients With Moderate Aortic Stenosis.

JACC Cardiovasc Imaging. 2023-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索